# FDA Inspection 1322452 - RxCrossroads 3PL LLC - June 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/rxcrossroads-3pl-llc/7a8ecf51-0ea0-446c-a9d3-c64c41463bf9
Source feed: FDA_Inspections

> FDA Inspection 1322452 for RxCrossroads 3PL LLC on June 09, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1322452
- Company Name: RxCrossroads 3PL LLC
- Inspection Date: 2026-06-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1204863 - 2023-05-09](https://www.keypedia.com/records/fda_inspections/rxcrossroads-3pl-llc/07c4b553-2740-4197-80dd-b2ef5016811b)
- [FDA Inspection 1084833 - 2018-11-15](https://www.keypedia.com/records/fda_inspections/rxcrossroads-3pl-llc/362b72ec-a6a6-43bd-a85c-b02c30357feb)

Company: https://www.keypedia.com/companies/rxcrossroads-3pl-llc/e9481857-3430-4246-9b9d-1b0cbbb34385

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d